Related Experiment Video
Updated: Jun 23, 2026
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Pediatric urologic rhabdomyosarcoma
1Pediatric Surgical Hospital, Ludwig-Maximilians-University Munich, Lindwurmstr, Munich, Germany. mstehr@med.uni-muenchen.de
Current Opinion in Urology
|May 15, 2009
Summary
Recent advancements in pediatric genitourinary rhabdomyosarcoma (RMS) research have improved survival rates. New therapeutic targets and imaging techniques offer hope for refractory cases.
Area of Science:
- Pediatric Oncology
- Genitourinary Cancers
- Rhabdomyosarcoma Research
Background:
- Genitourinary rhabdomyosarcoma (RMS) is a rare pediatric cancer requiring continuous research for improved outcomes.
- Collaborative studies have historically enhanced treatment protocols for genitourinary RMS.
Observation:
- Significant survival improvements have been achieved through collaborative efforts in treating genitourinary RMS.
- Refractory or relapsed genitourinary RMS remains a critical challenge in pediatric oncology.
- Advances in molecular biology are identifying new therapeutic targets and refining risk stratification for RMS.
Findings:
- Integrated fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) enhances diagnostic sensitivity.
- Alternative chemotherapy strategies have demonstrated efficacy.
- Modern radiotherapy techniques reduce local radiation doses, minimizing long-term side effects.
- Minimally invasive surgical approaches are preferred over disfiguring surgeries.
Implications:
- Modern treatment strategies, particularly in radiotherapy, can substantially decrease therapy-associated morbidity in pediatric RMS.
- Further research and extended follow-up are necessary to fully evaluate the long-term impact of new therapeutic approaches.
- Understanding tumor biology holds promise for developing novel, clinically relevant therapeutic targets for genitourinary RMS in the future.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...